MARIA TERESA
COIRAS LOPEZ
PROFESOR TITULAR
Universitat de Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Universitat de Barcelona (9)
2022
-
Transcriptomic Evidence of the Immune Response Activation in Individuals With Limb Girdle Muscular Dystrophy Dominant 2 (LGMDD2) Contributes to Resistance to HIV-1 Infection
Frontiers in Cell and Developmental Biology, Vol. 10
2021
-
Provirus reactivation is impaired in HIV-1 infected individuals on treatment with dasatinib and antiretroviral therapy
Biochemical Pharmacology, Vol. 192
2020
-
Dasatinib protects humanized mice from acute HIV-1 infection
Biochemical Pharmacology, Vol. 174
2019
-
The mutation of Transportin 3 gene that causes limb girdle muscular dystrophy 1F induces protection against HIV-1 infection
PLoS Pathogens, Vol. 15, Núm. 8
-
Tyrosine Kinase Inhibition: a New Perspective in the Fight against HIV
Current HIV/AIDS Reports, Vol. 16, Núm. 5, pp. 414-422
2018
-
Evaluation of resistance to HIV-1 infection ex vivo of PBMCs isolated from patients with chronic myeloid leukemia treated with different tyrosine kinase inhibitors
Biochemical Pharmacology, Vol. 156, pp. 248-264
-
Factors leading to the loss of natural elite control of HIV-1 infection
Journal of Virology, Vol. 92, Núm. 5
2017
-
Potential role of tyrosine kinase inhibitors during primary HIV-1 infection
Expert Review of Anti-Infective Therapy
2016
-
Dasatinib inhibits HIV-1 replication through the interference of SAMHD1 phosphorylation in CD4+ T cells
Biochemical Pharmacology, Vol. 106, pp. 30-45